Η National Ethics Committee within the framework of the principles of transparent Administration and the protected legitimate trust of the citizen, clarifies the following regarding the clinical studies process in the part that concerns its competence:
- The submission of RFIs by the AED during the evaluation of requests arises when ambiguities, deficiencies or outstanding issues are identified that require a response from the sponsor.
- RFIs are not submitted at the request of the sponsor to submit updated/new forms.
- The submission/addition by the sponsor of new/updated forms that are not related to the corresponding RFIs of the EED is not acceptable.
- At each meeting of the ADR, requests that have been submitted up to one month before the meeting date are evaluated.
- According to Ministerial Decision No. C5a/59676/22.12.2016 (Government Gazette B'/ 4131), the ADE holds two (2) regular meetings per month and extraordinary meetings, when required. The annual meeting schedule for 2025 has been prepared.
- Regarding the need to inform Greek patients about the clinical trials that are underway in the country, access is provided through the Clinical Trials Information System (CTIS) to available basic study data, in simple and understandable language for the Greek patient.
- The regulatory framework for in vitro diagnostic medical devices (IVDR) has not been amended.
National Ethics Committee





